News
-
-
-
-
-
PRESS RELEASE
Half yearly financial reports and audit reports/limited reviews / Terms of availability of the half-yearly financial report
ABL Texcell Diagnostics (Euronext Paris: ABLD) releases 2026 Half-Year Financial Report. Statutory auditor's report confirms accuracy. Products include PCR tests and genotyping services -
-
-
-
-